简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-01-10 14:05 Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
2023-01-10 09:48 Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
2023-01-10 09:35 Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
2023-01-06 18:16 Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
2023-01-06 15:09 New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality
2023-01-06 09:21 Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2023-01-05 09:42 Aptorum Group Announces Publication of a Co-authored Paper on its PathsDx Technology - a Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow for Liquid Biopsy based Diagnosis of Infectious Diseases on Illumina Platforms
2023-01-04 15:07 New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section
2023-01-03 10:39 Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
2022-12-30 10:37 Biocytogen Launches RenNano™ Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery
2022-12-23 09:12 Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
2022-12-21 09:27 Boehringer Ingelheim announces appointments to Board of Managing Directors
2022-12-20 09:40 Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
2022-12-19 14:30 Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
2022-12-19 10:09 Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
2022-12-16 17:55 Dermaliq Therapeutics Announces First Participant Randomized in Phase 1b/2 Trial Evaluating DLQ01 Solution for Treatment of Androgenic Alopecia
2022-12-16 13:11 Mori Memorial Foundation Issues GPCI-2022 & CPS-2022 Report
2022-12-16 09:48 Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
2022-12-16 09:39 CAS Introducing Transformational Capabilities to Accelerate Life Sciences Innovation
2022-12-14 15:34 AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting

Business Wire Weibo

Press Releases

Latest Releases